vcvibes

Age1

age1 Fund I, LP

Late investment periodEmerging manager

Late investment period: first sale Jul 2022, per Form D (fund age approximates vintage)

Email info@age1.com
Vintage
2022
Fund size
$55M (Form D)
Stages
Pre-seed, Seed, Series A
Sectors
Biotech
Regions
Global

01 · Thesis

age1 invests at the earliest stage, often before any money has been raised, in contrarian founders building biotech companies. It backs therapeutics, tools, and technologies targeting aging and age-related disease to extend healthy lifespan.Inferred from the firm's website

02 · Initial check

$500K to $4M (stated by the firm)

Stated by the firm (firm-level)

03 · Who to approach

Named on this fund's Form D

  • Alex Colville, Managing Member of the General Partner of the Issuer

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideage1 helps contrarian founders build generational biotech companies that extend healthy lifespan, starting at the earliest stage.

    age1 helps contrarian founders build generational biotech companies
    https://age1.com/

  • Firm-wideChecks of $500000 to $4000000

    We write checks anywhere from $500,000 to $4M.
    https://age1.com/

06 · Sources

  1. https://age1.com/
  2. https://www.sec.gov/Archives/edgar/data/1939171/000193917124000001/

Last verified: Oct 28, 2026